Skip to main content
. 2007 Jan;28(1):159–163.

Table 1:

Baseline characteristics of patients with acute ischemic stroke treated with IA thrombolysis

Variable Age <80 years (n = 81) Age ≥80 years (n = 33)
Mean age (range), years 64 (25–79) 86 (80–97)
Female, n (%) 38 (47%) 20 (61%)
Current tobacco use, n (%) 19 (23%) 7 (21%)
Hypertension, n (%) 58 (72%) 19 (58%)
Diabetes mellitus, n (%) 13 (16%) 4 (12%)
Hyperlipidemia, n (%) 27 (33%) 9 (27%)
Coronary artery disease, n (%) 25 (31%) 10 (30%)
Medium risk cardioembolic source, n (%) 11 (14%) 4 (12%)
High-risk cardioembolic source, n (%) 39 (48%) 20 (61%)
Prior stroke/TIA, n (%) 17 (21%)* 14 (42%)*
Peripheral vascular disease, n (%) 2 (2%) 3 (1%)
Antiplatelet therapy, n (%) 31 (38%) 10 (30%)
Warfarin therapy, n (%) 11 (14%) 7 (21%)
Weight, kg, mean ± SD 75.8 ± 13.0* 66.8 ± 10.8*
BP peak pretreatment, mm Hg, mean ± SD
    Systolic 160 ± 30 168 ± 38
    Diastolic 86 ± 18 92 ± 22
Glucose, mg/dL, mean ± SD 149 ± 46 146 ± 96
Platelets, ×103/μL, mean ± SD 233 ± 83 225 ± 68
Pretreatment NIHSS score, median (range) 16 (2–38) 17 (2–25)
Presence of hyperdense MCA sign, n (%) 15 (19%) 5 (15%)
Pathogenic mechanism
    Cardioembolic, n (%) 25 (31%) 12 (36%)
    Noncardioembolic, n (%) 37 (46%) 16 (48%)
    Undetermined, n (%) 19 (23%) 5 (16%)
Location: anterior circulation, n (%) 67 (83%) 29 (88%)
Target vessel localization, n (%)
    Extracranial internal carotid artery 12 (15%) 2 (6%)
    Intracranial internal carotid artery 10 (12%) 5 (15%)
    Both intracranial and extracranial internal carotid artery 1 (1%) 0 (0%)
    Middle cerebral artery 44 (54%) 17 (52%)
    Anterior cerebral artery 4 (5%) 2 (6%)
    Posterior cerebral artery 5 (5%) 1 (3%)
    Vertebrobasilar 11 (14%) 4 (12%)

Note:—IA indicates intra-arterial; TIA, transient ischemic attack; BP, blood pressure; NIHSS, National Institutes of Health Stroke Scale; MCA, middle cerebral artery.

*

P ≤ 0.05